Blood News and Research

RSS

Thousands of unknown chemicals and substances found in e-cigarettes

Vaping aerosols contain thousands of unknown chemicals and substances not disclosed by manufacturers, including industrial chemicals and caffeine, Johns Hopkins University researchers found.

6 Oct 2021

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Psychological therapy reduces the adverse biobehavioral effects of testicular cancer in young adult survivors, according to a pilot study led by the University of California, Irvine.

6 Oct 2021

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Elevated allostatic load was associated with a lower likelihood of completing chemotherapy and a lower overall survival rate in patients with lymph node-positive or high-risk lymph node-negative HER2-negative breast cancer, according to results presented at the 14th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held online October 6-8, 2021.

6 Oct 2021

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

Clot-busting drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. An aneurysm is a bulge in the wall of a blood vessel in the brain.

6 Oct 2021

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

Researchers at the KU Leuven Rega Institute and CD3 have developed an ultrapotent inhibitor of the dengue virus, which causes the tropical disease known as dengue.

6 Oct 2021

NRG Oncology launches highly anticipated colorectal cancer prevention study

Today, NRG Oncology activated the highly anticipated colorectal cancer prevention trial, FORTE, NRG-CC005. FORTE (Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps) is a large, randomized trial of surveillance colonoscopy for participants with a first-time diagnosis of 1 or 2 small benign polyps, called adenomas.

6 Oct 2021

Study finds increased risk for SARS-CoV-2 breakthrough infections in people with substance use disorders

An analysis of electronic health records of nearly 580,000 fully vaccinated people in the United States found that the risk of SARS-CoV-2 breakthrough infection among vaccinated patients with substance use disorders was low overall, but higher than the risk among vaccinated people without substance use disorders.

6 Oct 2021

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

A team of US-based scientists has recently revealed the changes in gene expression profiles associated with the long-term consequences of COVID-19.

6 Oct 2021

Exposure to air pollution and traffic noise over time may increase risk of developing heart failure

Exposure to air pollution and road traffic noise over the course of many years may be associated with an increased risk of developing heart failure, and the correlation appears to be even greater in people who are former smokers or have high blood pressure, according to new research published today in the Journal of the American Heart Association, an open access journal of the American Heart Association.

6 Oct 2021

Study shows lower SARS-CoV-2 infection rates in smokers

Coronavirus disease 2019 (COVID-19) primarily infects the lungs, later spreading through the bloodstream. The worst prognoses are mostly seen in ‘at-risk’ groups, such as the immunocompromised, elderly, or those suffering from respiratory conditions.

6 Oct 2021

Color-coded labels may encourage the purchase of more healthful products

A new analysis has integrated findings from 134 studies of the impact of color-coded nutrition labels and warnings found on the front of some food packaging, indicating that these labels do indeed appear to encourage more healthful purchases. Jing Song of Queen Mary University of London, UK, and colleagues present these findings in the open-access journal PLOS Medicine.

6 Oct 2021

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

In a new paper, researchers at the University of Illinois Chicago report that a drug approved for treating patients with autoimmune disease helped to prevent lung damage and death in mice infected with the SARS-CoV-2 virus, which causes COVID-19 in humans.

6 Oct 2021

Study: Six out of ten patients with “red flag” cancer symptoms not referred for urgent investigation

Six out of ten patients who show common "alarm" symptoms for cancer are not referred for urgent investigation, a largescale new study has revealed.

5 Oct 2021

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

Researchers in the United States and China have developed plasmid DNA immunogens that induce effective antibody responses in mice against the spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

Blood News and Research

Thousands of unknown chemicals and substances found in e-cigarettes

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Elevated allostatic load may impact treatment completion and breast cancer survival outcomes

Thrombolytic therapy may be safe for people with ischemic stroke and unruptured aneurysms

KU Leuven researchers develop an ultrapotent inhibitor of dengue virus

NRG Oncology launches highly anticipated colorectal cancer prevention study

Study finds increased risk for SARS-CoV-2 breakthrough infections in people with substance use disorders

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

Exposure to air pollution and traffic noise over time may increase risk of developing heart failure

Study shows lower SARS-CoV-2 infection rates in smokers

Color-coded labels may encourage the purchase of more healthful products

Autoimmune disease drug helps prevent lung damage, death in mice with SARS-CoV-2 infection

Study: Six out of ten patients with “red flag” cancer symptoms not referred for urgent investigation

Plasmid DNA vaccines induce effective antibody responses against SARS-CoV-2 in mice

Hollings Cancer Center researcher awarded NCI grant to pursue early investigator studies in leukemia

Cancer drug can restore memory and cognitive function in mice with Alzheimer’s symptoms

Plant-derived compound can be beneficial in protecting the brain against Alzheimer’s disease pathology

A possible protective genetic polymorphism in COVID-19

$35.1 million US grant focuses on investigating sleep disorder linked to neurodegeneration

Anti-CD20 therapy patients can develop immune responses after SARS-CoV-2 vaccination

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News